Answers are grounded in this paper and cite their sources.
Dasatinib is a key therapeutic option in patients with chronic myeloid leukemia. Previous case reports associated it with acute colitis. This is another report that demonstrates a link between dasatinib and chronic colitis akin to inflammatory bowel disease, in patients undergoing therapy with dasatinib for a prolonged time.
No takes yet. Share an insight, caveat, or question.
Campiotti et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: